Trial intelligence / Profile preview

Timing of intubation in modified rapid sequence induction with remifentanil

2009-014346-28Phase 4Completed

Sponsor
Erasmus Hospital
Start
Sep 2009
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of remifentanil and propofol, sponsored by Erasmus Hospital. Primary endpoint: Time to orotracheal intubation. Started Sep 2009; status: completed.

02

Drugs

remifentanilpropofol

Beyond the preview

Go deeper on 2009-014346-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-014346-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call